No overall algorithm. considerations Describe anticipated barriers to application of the recommendations. Provide reference to any auxiliary documents for providers or patients that are intended to facilitate implementation. Suggest review criteria for measuring changes in care when the guideline is implemented. These recommendations are global. Review criteria were not suggested because implementation with prioritization and development of review criteria have to proceed locally. Furthermore, most recommendations are discretionary, requiring substantial discussion among stakeholders before they can be adopted as review criteria. Suggestions were provided for future research. BP, blood pressure; CKD, chronic kidney disease; CKD ND, non dialysis-dependent CKD; CVD, cardiovascular disease; GRADE, Grading of Recommendations Assessment, Development and Evaluation; KDIGO, Kidney Disease: Improving Global Outcomes; RCT, randomized controlled trial. methods for guideline development Biographic and disclosure information Gavin J Becker, MD, FRACP (Work Group Co-Chair), is Professor and Director of Nephrology at the Royal Melbourne Hospital and Clinical Director of Renal and Endocrinology Services at Melbourne Health. He maintains an active role in numerous professional societies including serving as a current member of the International Society of Nephrology (ISN) Executive Committee, Cochrane Renal Collaboration Advisory Board and Co-Chair of the World Health Organization ICD-11Renal Diseases Working Group. He is a Past President of the Asian Pacific Society of Nephrology. Dr Becker has published over 300 papers, chapters and books and presently serves as Associate Editor for Nephrology Dialysis Transplantation. He has served as Editor of Nephrology, Associate Editor or on the editorial boards of the Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Nephron, and Journal of Nephrology. 